What they were paid
Editas Medicine Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $47,500 | $0 | $52,463 | $0 | $99,963 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Editas Medicine, Inc. DEF 14A filed April 28, 2026, accession 0001650664-26-000037, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Editas Medicine pays directors a $40,000 cash retainer and $300,000 in Stock Options.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Editas Medicine board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Hirsch | Independent Director | $118,713 |
| Bernadette Connaughton | Independent Director | $112,463 |
| Elliott Levy, M.D | Independent Director | $101,213 |
| Gilmore O'Neill, M.B., M.M.Sc | Director | $0 |
| Jessica Hopfield, Ph.D | Chair of the Board | $146,213 |
The full Editas Medicine compensation record
free company briefThis page is one director within Editas Medicine's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat